AstraZeneca plc (ADR) (NYSE:AZN)

Monkey evil

Top Analyst Upgrades and Downgrades: Apple, MarkWest, NII Holdings, RF Micro, SodaStream and More

Earnings season is basically over, and stocks are challenging new highs almost daily. Investors are still looking to avoid getting caught up in the next sell-off, but they are looking ...
Read Full Story »
Pills

Horizon Pharma Deal Ramps Up Profitability Timeline

Horizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with AstraZeneca PLC (NYSE: AZN) for the U.S. rights to VIMOVO. ...
Read Full Story »
job_dissatisfaction_2

Big Pharma and 100,000 Jobs at Risk

Merck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big pharmaceutical company's R&D operations. Since the return on research investment ...
Read Full Story »
biotech

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

Investors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the population. From obesity to food allergies to prostate cancer, the ...
Read Full Story »
global economy

UBS Offers Eight Well-Known International Large Cap Dividend Ruler Stocks

With yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact of higher rates on stocks continues to be top of ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Carnival, Intel, Micron, Pulte and More

Investors are on the hunt for solid research ideas now that stocks have pulled back a bit. 24/7 Wall St. reviews many analyst research calls from Wall Street and from ...
Read Full Story »
pills

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

Although Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a stalking horse bid, that’s what many observers expect to be ...
Read Full Story »
Money, US, $100 bills

UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects

Over the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66% to 2.17%. The overall equity market has rallied 3.8% during ...
Read Full Story »
Bull and Bear figures

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Sink Later

U.S. equity markets opened slightly higher this morning but lost steam in the afternoon to finish with a loss for the first Tuesday in a record streak of Tuesdays. In ...
Read Full Story »
global economy

UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More

Total return is always the name of the game when it comes to investing success. Stocks that pay dividends on a regular basis help smooth out the rough spots when ...
Read Full Story »
health care

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

The world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating billions upon billions in annual sales in the United States ...
Read Full Story »
Money, US, $100 bills

UBS Has Top Dividend Ruler Stocks From Around the World (AZN, TOT, INTC, BNS, NU, SNY, OXY, UPS, JNJ, CLX)

Investors love dividends, and this component of investing plays a very important part of the total return through time. Buying stocks that combine solid and growing dividends with a potential ...
Read Full Story »
Wall St Bull statue

Top Key Call Stocks From UBS Global Ideas of the Week (LOW, TWX, BUD, APC, KEY, AZN, RIO, UBS)

When the holidays wound down and we started off 2013, all the Wall St. firms started to put out their top stock picks for the year. We covered those various ...
Read Full Story »
Pills

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

The U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’ ...
Read Full Story »
Money, US, $100 bills

Big Dividend Yields From UBS Dividend Ruler Stock List (UBS, AZN, TOT, INTC, BTI, RTN, TD, NU, UL, NEE, JNJ)

S&P 500 dividend growth continues to outpace earnings growth, a trend that likely will continue for a few more years. Low yields on fixed income alternatives and historically low dividend ...
Read Full Story »